speb/financial-data huggingface dataset:
NURS.V balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 811639.00
NURS.V balance_sheet (annual, 2023-12-31) — Dueto Related Parties Non Current: 0.00
NURS.V income_statement (annual, 2023-12-31) — EBIT: -1465134.00
NURS.V income_statement (annual, 2023-12-31) — EBITDA: -1356745.00
NURS.V cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 24556.00
NURS.V cash_flow (annual, 2023-12-31) — End Cash Position: 1783787.00
NURS.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: 31212.00
NURS.V cash_flow (annual, 2023-12-31) — Free Cash Flow: -613673.00
NURS.V income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -23849.00
NURS.V balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -90503.00
NURS.V income_statement (annual, 2023-12-31) — General And Administrative Expense: 5532298.00
NURS.V balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 392959.00
NURS.V balance_sheet (annual, 2023-12-31) — Gross PPE: 2693.00
NURS.V income_statement (annual, 2023-12-31) — Gross Profit: 4961450.00
NURS.V income_statement (annual, 2023-12-31) — Insurance And Claims: 99583.00
NURS.V income_statement (annual, 2023-12-31) — Interest Expense: 605.00
NURS.V income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 605.00
NURS.V income_statement (annual, 2023-12-31) — Interest Income: 21102.00
NURS.V income_statement (annual, 2023-12-31) — Interest Income Non Operating: 21102.00
NURS.V balance_sheet (annual, 2023-12-31) — Inventory: 103753.00
NURS.V balance_sheet (annual, 2023-12-31) — Invested Capital: -1830917.00
NURS.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: -302225.00
NURS.V cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Leases: 38615.00
NURS.V cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -19174.00
NURS.V cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
NURS.V income_statement (annual, 2023-12-31) — Net Income: -1937351.00
NURS.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1937351.00
NURS.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1937351.00
NURS.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1937351.00
NURS.V income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1937351.00
NURS.V cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1937351.00
NURS.V income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1937351.00
NURS.V cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -208639.00
NURS.V income_statement (annual, 2023-12-31) — Net Interest Income: -448368.00
NURS.V cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -19174.00
NURS.V cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -19174.00
NURS.V income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -448368.00
NURS.V cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 50386.00
NURS.V cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -90729.00
NURS.V balance_sheet (annual, 2023-12-31) — Net PPE: 2693.00
NURS.V cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2857.00
NURS.V balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -2223876.00
NURS.V balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 58869.00
NURS.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 27475.00
NURS.V balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 27475.00
NURS.V balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 85000.00
NURS.V income_statement (annual, 2023-12-31) — Normalized EBITDA: -1332896.00
NURS.V income_statement (annual, 2023-12-31) — Normalized Income: -1913502.00
NURS.V cash_flow (annual, 2023-12-31) — Operating Cash Flow: -402177.00
NURS.V income_statement (annual, 2023-12-31) — Operating Income: -1465134.00
NURS.V income_statement (annual, 2023-12-31) — Operating Revenue: 11509496.00
NURS.V balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 38319005.00
NURS.V balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -90503.00
NURS.V balance_sheet (annual, 2023-12-31) — Other Equity Interest: 451535.00
NURS.V income_statement (annual, 2023-12-31) — Other Gand A: 2961293.00
NURS.V income_statement (annual, 2023-12-31) — Other Income Expense: -23849.00
NURS.V balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 392959.00
NURS.V cash_flow (annual, 2023-12-31) — Other Non Cash Items: 605.00
NURS.V income_statement (annual, 2023-12-31) — Other Operating Expenses: 591502.00
NURS.V balance_sheet (annual, 2023-12-31) — Other Payable: 369612.00
NURS.V balance_sheet (annual, 2023-12-31) — Other Properties: 2693.00
NURS.V income_statement (annual, 2023-12-31) — Other Taxes: 605.00
NURS.V balance_sheet (annual, 2023-12-31) — Payables: 2594601.00
NURS.V balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2715618.00
NURS.V balance_sheet (annual, 2023-12-31) — Prepaid Assets: 121402.00
NURS.V income_statement (annual, 2023-12-31) — Pretax Income: -1937351.00
NURS.V cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Properties: 0.00
NURS.V cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -208639.00
NURS.V cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2857.00
NURS.V balance_sheet (annual, 2023-12-31) — Receivables: 55545.00
NURS.V income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 6548046.00
NURS.V income_statement (annual, 2023-12-31) — Reconciled Depreciation: 108389.00
NURS.V income_statement (annual, 2023-12-31) — Rent And Landing Fees: 236017.00
NURS.V income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 236017.00
NURS.V cash_flow (annual, 2023-12-31) — Repayment Of Debt: -19174.00
NURS.V cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
NURS.V income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Retained Earnings: -8725467.00
NURS.V income_statement (annual, 2023-12-31) — Salaries And Wages: 2235405.00
NURS.V income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 193790.00
NURS.V income_statement (annual, 2023-12-31) — Selling General And Administration: 5726088.00
NURS.V balance_sheet (annual, 2023-12-31) — Share Issued: 38319005.00
NURS.V income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
NURS.V cash_flow (annual, 2023-12-31) — Stock Based Compensation: 444709.00
NURS.V balance_sheet (annual, 2023-12-31) — Stockholders Equity: -1830917.00
NURS.V balance_sheet (annual, 2023-12-31) — Tangible Book Value: -2223876.00
NURS.V income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
NURS.V income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Assets: 2604008.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Capitalization: -1830917.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Debt: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -1830917.00
NURS.V income_statement (annual, 2023-12-31) — Total Expenses: 12974630.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4434925.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 539521.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 27475.00
NURS.V income_statement (annual, 2023-12-31) — Total Other Finance Cost: 469470.00
NURS.V balance_sheet (annual, 2023-12-31) — Total Tax Payable: 579626.00
NURS.V income_statement (annual, 2023-12-31) — Total Unusual Items: -23849.00
NURS.V income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -23849.00
NURS.V balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (annual, 2023-12-31) — Working Capital: -2342963.00
NURS.V income_statement (quarterly, 2024-09-30) — Amortization: 47094.00
NURS.V income_statement (quarterly, 2024-09-30) — Amortization Of Intangibles Income Statement: 47094.00
NURS.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 39621023.00
NURS.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 63691.00
NURS.V cash_flow (quarterly, 2024-09-30) — Change In Payable: 63691.00
NURS.V cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
NURS.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 39621023.00
NURS.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
NURS.V balance_sheet (quarterly, 2024-09-30) — Duefrom Related Parties Non Current: 8099.00
NURS.V balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 0.00
NURS.V income_statement (quarterly, 2024-09-30) — Interest Expense: 0.00
NURS.V income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 0.00
NURS.V balance_sheet (quarterly, 2024-09-30) — Inventory: 93138.00
NURS.V cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 54765.00
NURS.V balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 8099.00
NURS.V balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 85000.00
NURS.V income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 108832.00
NURS.V cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
NURS.V cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
NURS.V balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 6057.00
NURS.V income_statement (annual, 2024-12-31) — +Operating Expense: 5404082.00
NURS.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 1159941.00
NURS.V income_statement (annual, 2024-12-31) — +Total Revenue: 16044716.00
NURS.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 4040578.00
NURS.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 1005916.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1005916.00
NURS.V balance_sheet (annual, 2024-12-31) — Accounts Receivable: 47840.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 47840.00
NURS.V cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 98860.00
NURS.V income_statement (annual, 2024-12-31) — Basic Average Shares: 39147614.00
NURS.V income_statement (annual, 2024-12-31) — Basic EPS: -0.01
NURS.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1783787.00
NURS.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 1212140.00
NURS.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -1182427.00
NURS.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -344911.00
NURS.V balance_sheet (annual, 2024-12-31) — Capital Stock: 7095557.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 7095557.00
NURS.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1186942.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 1186942.00
NURS.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1186942.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1186942.00
NURS.V cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Cash Financial: 1186942.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 1186942.00
NURS.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -63462.00
NURS.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 4558.00
NURS.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1178074.00
NURS.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -344911.00
NURS.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 856922.00
NURS.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 470678.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Account Payable: 436584.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Inventory: 4893.00
NURS.V cash_flow (quarterly, 2024-12-31) — Change In Inventory: -5722.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 15499.00
NURS.V cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 237987.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Payable: 436584.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 436584.00
NURS.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 28626.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -35771.00
NURS.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -103798.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Receivables: -53987.00
NURS.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: 43406.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Tax Payable: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Change In Working Capital: 367218.00
NURS.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 200499.00
NURS.V cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -53987.00
NURS.V cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 37349.00
NURS.V cash_flow (annual, 2024-12-31) — Changes In Cash: -384614.00
NURS.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: 130325.00
NURS.V balance_sheet (annual, 2024-12-31) — Common Stock: 7095557.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 7095557.00
NURS.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: -1768743.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -1768743.00
NURS.V cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Common Stock Payments: -7425.00
NURS.V income_statement (annual, 2024-12-31) — Cost Of Revenue: 10348463.00
NURS.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 2668627.00
NURS.V balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 306808.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 306808.00
NURS.V balance_sheet (annual, 2024-12-31) — Current Assets: 1580865.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 1580865.00
NURS.V balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1732685.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 1732685.00
NURS.V balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1732685.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 1732685.00
NURS.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 4041402.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 4041402.00
NURS.V cash_flow (annual, 2024-12-31) — Deferred Income Tax: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Deferred Tax: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 181136.00
NURS.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 62853.00
NURS.V income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 181136.00
NURS.V income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 62853.00
NURS.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 181136.00
NURS.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 62853.00
NURS.V income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 181136.00
NURS.V income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 62853.00
NURS.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 39147614.00
NURS.V income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
NURS.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 20577.00
NURS.V balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 85200.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 85200.00
NURS.V balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Non Current: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Non Current: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Dueto Related Parties Non Current: 833974.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Non Current: 833974.00
NURS.V income_statement (annual, 2024-12-31) — EBIT: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — EBIT: 717917.00
NURS.V income_statement (annual, 2024-12-31) — EBITDA: -224033.00
NURS.V income_statement (quarterly, 2024-12-31) — EBITDA: 780770.00
NURS.V income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -212231.00
NURS.V cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: -155523.00
NURS.V cash_flow (annual, 2024-12-31) — End Cash Position: 1186942.00
NURS.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 1186942.00
NURS.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: -63462.00
NURS.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 4558.00
NURS.V cash_flow (annual, 2024-12-31) — Free Cash Flow: -325505.00
NURS.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 125767.00
NURS.V income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 19774.00
NURS.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 9284.00
NURS.V balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -263592.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -263592.00
NURS.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 5264208.00
NURS.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 1517347.00
NURS.V balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1526274.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 1526274.00
NURS.V balance_sheet (annual, 2024-12-31) — Gross PPE: 1616.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1616.00
NURS.V income_statement (annual, 2024-12-31) — Gross Profit: 5696253.00
NURS.V income_statement (quarterly, 2024-12-31) — Gross Profit: 1371951.00
NURS.V income_statement (annual, 2024-12-31) — Insurance And Claims: 112819.00
NURS.V income_statement (quarterly, 2024-12-31) — Insurance And Claims: 28672.00
NURS.V income_statement (annual, 2024-12-31) — Interest Expense: 0.00
NURS.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
NURS.V income_statement (annual, 2024-12-31) — Interest Income: 16238.00
NURS.V income_statement (quarterly, 2024-12-31) — Interest Income: 3100.00
NURS.V income_statement (annual, 2024-12-31) — Interest Income Non Operating: 16238.00
NURS.V income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 3100.00
NURS.V cash_flow (annual, 2024-12-31) — Interest Paid Cff: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Inventory: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Inventory: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Invested Capital: -1768743.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: -1768743.00
NURS.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1178074.00
NURS.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -344911.00
NURS.V balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
NURS.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -7425.00
NURS.V income_statement (annual, 2024-12-31) — Net Income: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Income: 20577.00
NURS.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 20577.00
NURS.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 20577.00
NURS.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 20577.00
NURS.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 20577.00
NURS.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -405169.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 20577.00
NURS.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 20577.00
NURS.V cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -1182427.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -344911.00
NURS.V income_statement (annual, 2024-12-31) — Net Interest Income: -717114.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -200717.00
NURS.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
NURS.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -717114.00
NURS.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -200717.00
NURS.V cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -89037.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -21017.00
NURS.V cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 4353.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Net PPE: 1616.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 1616.00
NURS.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
NURS.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -3295017.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -3295017.00
NURS.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2122.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 2122.00
NURS.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 2122.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 2122.00
NURS.V balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 0.00
NURS.V income_statement (annual, 2024-12-31) — Normalized EBITDA: -243807.00
NURS.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 771486.00
NURS.V income_statement (annual, 2024-12-31) — Normalized Income: -424943.00
NURS.V income_statement (quarterly, 2024-12-31) — Normalized Income: 12685.60
NURS.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: 856922.00
NURS.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 470678.00
NURS.V income_statement (annual, 2024-12-31) — Operating Income: 292171.00
NURS.V income_statement (quarterly, 2024-12-31) — Operating Income: 212010.00
NURS.V income_statement (annual, 2024-12-31) — Operating Revenue: 16044716.00
NURS.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 4040578.00
NURS.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 40324933.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 40324933.00
NURS.V balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -263592.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -263592.00
NURS.V balance_sheet (annual, 2024-12-31) — Other Equity Interest: 529928.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 529928.00
NURS.V income_statement (annual, 2024-12-31) — Other Gand A: 2382997.00
NURS.V income_statement (quarterly, 2024-12-31) — Other Gand A: 820550.00
NURS.V income_statement (annual, 2024-12-31) — Other Income Expense: 19774.00
NURS.V income_statement (quarterly, 2024-12-31) — Other Income Expense: 9284.00
NURS.V balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1526274.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1526274.00
NURS.V income_statement (annual, 2024-12-31) — Other Operating Expenses: -254510.00
NURS.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -499443.00
NURS.V balance_sheet (annual, 2024-12-31) — Other Payable: 632748.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Other Payable: 632748.00
NURS.V balance_sheet (annual, 2024-12-31) — Other Properties: 1616.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 1616.00
NURS.V balance_sheet (annual, 2024-12-31) — Other Receivables: 3497.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Other Receivables: 3497.00
NURS.V income_statement (annual, 2024-12-31) — Other Taxes: 12880.00
NURS.V balance_sheet (annual, 2024-12-31) — Payables: 2001909.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Payables: 2001909.00
NURS.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2308717.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 2308717.00
NURS.V balance_sheet (annual, 2024-12-31) — Prepaid Assets: 230937.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 230937.00
NURS.V income_statement (annual, 2024-12-31) — Pretax Income: -405169.00
NURS.V income_statement (quarterly, 2024-12-31) — Pretax Income: 20577.00
NURS.V cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 33000.00
NURS.V cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -1182427.00
NURS.V cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -344911.00
NURS.V cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
NURS.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Receivables: 162986.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Receivables: 162986.00
NURS.V balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -4915.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Receivables Adjustments Allowances: -4915.00
NURS.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 10348463.00
NURS.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2668627.00
NURS.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 181136.00
NURS.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 62853.00
NURS.V income_statement (annual, 2024-12-31) — Rent And Landing Fees: 244177.00
NURS.V income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 78346.00
NURS.V income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 244177.00
NURS.V income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 78346.00
NURS.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
NURS.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -7425.00
NURS.V balance_sheet (annual, 2024-12-31) — Retained Earnings: -9130636.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -9130636.00
NURS.V income_statement (annual, 2024-12-31) — Salaries And Wages: 2524215.00
NURS.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 589779.00
NURS.V income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 213248.00
NURS.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 66304.00
NURS.V income_statement (annual, 2024-12-31) — Selling General And Administration: 5477456.00
NURS.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1583651.00
NURS.V balance_sheet (annual, 2024-12-31) — Share Issued: 40324933.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 40324933.00
NURS.V income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
NURS.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 614877.00
NURS.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 87889.00
NURS.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: -1768743.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -1768743.00
NURS.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: -3295017.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -3295017.00
NURS.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NURS.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 1392.60
NURS.V income_statement (annual, 2024-12-31) — Tax Provision: 0.00
NURS.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
NURS.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.15
NURS.V balance_sheet (annual, 2024-12-31) — Taxes Receivable: 31364.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 31364.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Assets: 3108755.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 3108755.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Capitalization: -1768743.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -1768743.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -1768743.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -1768743.00
NURS.V income_statement (annual, 2024-12-31) — Total Expenses: 15752545.00
NURS.V income_statement (quarterly, 2024-12-31) — Total Expenses: 3828568.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4877498.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 4877498.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1527890.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 1527890.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 836096.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 836096.00
NURS.V income_statement (annual, 2024-12-31) — Total Other Finance Cost: 733352.00
NURS.V income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 203817.00
NURS.V balance_sheet (annual, 2024-12-31) — Total Tax Payable: 363245.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 363245.00
NURS.V income_statement (annual, 2024-12-31) — Total Unusual Items: 19774.00
NURS.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: 9284.00
NURS.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 19774.00
NURS.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 9284.00
NURS.V balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (annual, 2024-12-31) — Working Capital: -2460537.00
NURS.V balance_sheet (quarterly, 2024-12-31) — Working Capital: -2460537.00
NURS.V income_statement (annual, 2024-12-31) — Write Off: 0.00
NURS.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 1425667.00
NURS.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 4540122.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1018615.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 53503.00
NURS.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 41761299.00
NURS.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
NURS.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1186942.00
NURS.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -335275.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 10972435.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6043629.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6043629.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 6043629.00
NURS.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4833120.00
NURS.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -335275.00
NURS.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 354319.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -74793.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 0.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 351859.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Payable: -74793.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -74793.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -110442.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 24283.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 0.00
NURS.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 190907.00
NURS.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 24283.00
NURS.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 4852164.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 10972435.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3149062.00
NURS.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 4796987.00
NURS.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3035657.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 195165.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 6521531.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2083512.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2083512.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4361025.00
NURS.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 101004.00
NURS.V income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 101004.00
NURS.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 101004.00
NURS.V income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 101004.00
NURS.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 42028619.00
NURS.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
NURS.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 20903.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 85123.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Non Current: 812493.00
NURS.V income_statement (quarterly, 2025-03-31) — EBIT: 20903.00
NURS.V income_statement (quarterly, 2025-03-31) — EBITDA: 121907.00
NURS.V income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
NURS.V cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 0.00
NURS.V cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 4523.00
NURS.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 6043629.00
NURS.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4833120.00
NURS.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 19044.00
NURS.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -4834.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -262843.00
NURS.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1196345.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1801736.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2466.00
NURS.V income_statement (quarterly, 2025-03-31) — Gross Profit: 1504465.00
NURS.V income_statement (quarterly, 2025-03-31) — Insurance And Claims: 27727.00
NURS.V income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
NURS.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
NURS.V income_statement (quarterly, 2025-03-31) — Interest Income: 98728.00
NURS.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 98728.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3149062.00
NURS.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -335275.00
NURS.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 4796987.00
NURS.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 4796987.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Income: 20903.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 20903.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 20903.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 20903.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 20903.00
NURS.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 20903.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 20903.00
NURS.V cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -334054.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -53061.00
NURS.V cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
NURS.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -53061.00
NURS.V cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -21528.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 2466.00
NURS.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1221.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1347326.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3153.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 3153.00
NURS.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 126741.00
NURS.V income_statement (quarterly, 2025-03-31) — Normalized Income: 25011.90
NURS.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 354319.00
NURS.V income_statement (quarterly, 2025-03-31) — Operating Income: 78798.00
NURS.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 4540122.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 44796983.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -262843.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1549203.00
NURS.V income_statement (quarterly, 2025-03-31) — Other Gand A: 546911.00
NURS.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -4834.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1801736.00
NURS.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 52207.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Other Payable: 648522.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 2466.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Payables: 2082348.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2277513.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 339276.00
NURS.V income_statement (quarterly, 2025-03-31) — Pretax Income: 20903.00
NURS.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 57661.00
NURS.V cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -334054.00
NURS.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1221.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Receivables: 138626.00
NURS.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3035657.00
NURS.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 101004.00
NURS.V income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 68216.00
NURS.V income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 68216.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -9109733.00
NURS.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 553491.00
NURS.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 76111.00
NURS.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1272456.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 44796983.00
NURS.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 41505.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3149062.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1347326.00
NURS.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -725.10
NURS.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 8325733.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3149062.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3149062.00
NURS.V income_statement (quarterly, 2025-03-31) — Total Expenses: 4461324.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5176671.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1804202.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 815646.00
NURS.V income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 151789.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 415211.00
NURS.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -4834.00
NURS.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4834.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 2160506.00
NURS.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 1717369.00
NURS.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 5376519.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1112946.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 204742.00
NURS.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 44915304.00
NURS.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
NURS.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 6043629.00
NURS.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -381535.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 11139843.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6104118.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6104118.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 6104118.00
NURS.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 57915.00
NURS.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -381535.00
NURS.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 214211.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2154.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Inventory: 0.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 119726.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Payable: -2154.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2154.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 65906.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -151238.00
NURS.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 32240.00
NURS.V cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -177873.00
NURS.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -109409.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 11139843.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3413485.00
NURS.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
NURS.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3446317.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 163509.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 6661650.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2200549.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2200549.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4473685.00
NURS.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 107129.00
NURS.V income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 107129.00
NURS.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 107129.00
NURS.V income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 107129.00
NURS.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 46171922.00
NURS.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
NURS.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 49867.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 79419.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Non Current: 749879.00
NURS.V income_statement (quarterly, 2025-06-30) — EBIT: 212833.00
NURS.V income_statement (quarterly, 2025-06-30) — EBITDA: 319962.00
NURS.V cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 169898.00
NURS.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 6104118.00
NURS.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 57915.00